Safety and Tolerability of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars
Clinical trial NCT06210919 · COMPLETED
Trial details
- NCT number
- NCT06210919
- Sponsor
- CellinCells
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-06
- Primary completion
- 2024-12-10
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.